Bausch & Lomb (NYSE: BLCO) director receives 15,842-share RSU grant

Rhea-AI Filing Summary

Alfonso Eduardo reported acquisition or exercise transactions in this Form 4 filing.

Bausch & Lomb Corp director Alfonso Eduardo received an equity award linked to 15,842 common shares of the company. The Form 4 shows this as a grant or award, not an open-market purchase, at a reference price of $15.78 per share. This reflects his annual grant of restricted share units under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan for non-employee directors. The RSUs will be settled in common shares and are scheduled to vest immediately before the conclusion of the next annual meeting of shareholders. Following this award, Eduardo directly holds 31,072 common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Alfonso Eduardo

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	15,842	$15.78	$250K

Holdings After Transaction: Common Shares, No Par Value — 31,072 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU-related shares granted: 15,842 shares Reference price per share: $15.78/share Shares held after grant: 31,072 shares

3 metrics

RSU-related shares granted 15,842 shares Annual equity award to non-employee director

Reference price per share $15.78/share Value used for the reported grant

Shares held after grant 31,072 shares Director’s direct holdings post-transaction

Key Terms

restricted share units ("RSUs"), 2022 Omnibus Incentive Plan, annual meeting of shareholders

3 terms

restricted share units ("RSUs") financial

"Reflects the annual grant of restricted share units ("RSUs") to non-employee directors"

2022 Omnibus Incentive Plan financial

"under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated"

annual meeting of shareholders financial

"scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alfonso Eduardo

(Last) (First) (Middle)

C/O BAUSCH + LOMB CORPORATION

520 APPLEWOOD CRESCENT

(Street)

VAUGHAN L4K 4B4

(City) (State) (Zip)

ONTARIO, CANADA

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	05/26/2026		A		15,842(1)	A	$15.78	31,072	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.

	/s/ Debra E. Levin, attorney-in-fact	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Bausch & Lomb (BLCO) director Alfonso Eduardo report?

Alfonso Eduardo reported receiving an equity award tied to 15,842 common shares of Bausch & Lomb. This was a grant of restricted share units under the company’s 2022 Omnibus Incentive Plan for non-employee directors, not an open-market stock purchase.

Is the BLCO transaction by Alfonso Eduardo a stock purchase or a compensation grant?

The transaction is a compensation-related grant, not a market purchase. It reflects the annual award of restricted share units to a non-employee director under Bausch & Lomb’s 2022 Omnibus Incentive Plan, with future settlement in common shares upon vesting.

How many Bausch & Lomb shares does Alfonso Eduardo hold after this Form 4?

After the reported grant, Alfonso Eduardo holds 31,072 common shares of Bausch & Lomb directly. This total includes the new award linked to 15,842 restricted share units, which will settle in shares once they vest before the next annual shareholder meeting.

At what reference price were the BLCO shares in Alfonso Eduardo’s grant valued?

The grant is recorded at a reference price of $15.78 per Bausch & Lomb common share. This price reflects the value used in the Form 4 disclosure and does not indicate an open-market transaction, since the award is a restricted share unit grant.

When do Alfonso Eduardo’s Bausch & Lomb restricted share units vest?

The restricted share units granted to Alfonso Eduardo are scheduled to vest immediately before the conclusion of Bausch & Lomb’s next annual meeting of shareholders. Once vested, these RSUs are settled in common shares with no par value issued by the company.